SCHEMBL11036862

SCHEMBL11036862

CCCCCCCCn1cnc2cc(OC(=O)Cc3ccccc3)ccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G4A P47712 1/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ NR1I2 O75469 2/20 0.46
▸ MAPT P10636 4/20 0.45
▸ FGFR1 P11362 1/20 0.45
▸ LMNA P02545 4/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ HTT P42858 2/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ HPGD P15428 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ CNR2 P34972 1/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7874916 0.76 MAPT (0.55) KMT2ANR1I2MAPTFGFR1LMNA
SCHEMBL2361153 0.74 HPGD (0.63) PLA2G4ANR1I2MAPTFGFR1LMNA
SCHEMBL18250739 0.73 LMNA (0.59) KMT2ANR1I2MAPTFGFR1LMNA
SCHEMBL9853306 0.73 LMNA (0.59) KMT2ANR1I2MAPTFGFR1LMNA
SCHEMBL9038430 0.73 LMNA (0.59) KMT2ANR1I2MAPTFGFR1LMNA
SCHEMBL9853312 0.73 LMNA (0.59) KMT2ANR1I2MAPTFGFR1LMNA
SCHEMBL9041559 0.73 LMNA (0.59) KMT2ANR1I2MAPTFGFR1LMNA
SCHEMBL3806522 0.73 HDAC1 (0.51) KMT2AMAPTLMNASMN1; SMN2HTT
SCHEMBL20377243 0.72 PLA2G4A (0.58) PLA2G4AFGFR1TP53TSHR
SCHEMBL19848227 0.72 MAPT (0.58) MAPTFGFR1LMNASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4492708-A Antiviral benzimidazoles ELI LILLY AND COMPANY (US) 1985-01-08 — — US disclosed
EP-0111993-A2 Improvements in or relating to benzimidazoles ELI LILLY AND COMPANY (US) 1984-06-27 — — EP disclosed
Send feedback